These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27752803)

  • 1. Nigella sativa Oil Reduces Extrapyramidal Symptoms (EPS)-Like Behavior in Haloperidol-Treated Rats.
    Malik T; Hasan S; Pervez S; Fatima T; Haleem DJ
    Neurochem Res; 2016 Dec; 41(12):3386-3398. PubMed ID: 27752803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine reverses altered locomotor activity and tyrosine hydroxylase immunoreactivity in rat caudate putamen following long-term haloperidol treatment.
    Zhang Y; Xu H; He J; Yan B; Jiang W; Li X; Li XM
    Neurosci Lett; 2007 Jun; 420(1):66-71. PubMed ID: 17466452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
    Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEPHROPROTECTIVE AND DIURETIC EFFECT OF
    Benhelima A; Kaid-Omar Z; Hemida H; Benmahdi T; Addou A
    Afr J Tradit Complement Altern Med; 2016; 13(6):204-214. PubMed ID: 28480381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
    Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and neurochemical effects of alpha lipoic acid associated with omega-3 in tardive dyskinesia induced by chronic haloperidol in rats.
    de Araújo DP; Camboim TGM; Silva APM; Silva CDF; de Sousa RC; Barbosa MDA; Oliveira LC; Cavalcanti JRLP; Lucena EES; Guzen FP
    Can J Physiol Pharmacol; 2017 Jul; 95(7):837-843. PubMed ID: 28329449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of haloperidol-induced extrapyramidal side effects in cebus monkeys by 8-hydroxy-2-(di-n-propylamino)tetralin and its enantiomers.
    Christoffersen CL; Meltzer LT
    Neuropsychopharmacology; 1998 May; 18(5):399-402. PubMed ID: 9536454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutic approaches of natural oil from black seeds and its underlying mechanisms against kidney dysfunctions in haloperidol-induced male rats.
    Akintunde JK; Abubakar OK
    Drug Metab Pers Ther; 2017 May; 32(2):97-107. PubMed ID: 28384101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats.
    Shireen E; Naeem S; Inam QU; Haleem DJ
    Pak J Pharm Sci; 2013 Mar; 26(2):271-6. PubMed ID: 23455196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of nifedipine as a corrector of extrapyramidal side-effects of classical neuroleptics].
    Popov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):28-33. PubMed ID: 18577931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical and behavioral effects of Nigella sativa and Olea europaea oil in rats.
    Cheema MAR; Nawaz S; Gul S; Salman T; Naqvi S; Dar A; Haleem DJ
    Nutr Neurosci; 2018 Apr; 21(3):185-194. PubMed ID: 27868798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Report: Protective effects of rice bran oil in haloperidol-induced tardive dyskinesia and serotonergic responses in rats.
    Samad N; Haleem MA; Haleem DJ
    Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1467-71. PubMed ID: 27592482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice.
    Arora D; Mudgal J; Nampoothiri M; Mallik SB; Kinra M; Hall S; Anoopkumar-Dukie S; Grant GD; Rao CM
    Metab Brain Dis; 2018 Aug; 33(4):1045-1051. PubMed ID: 29516413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An animal model to study the molecular basis of tardive dyskinesia.
    Bishnoi M; Boparai RK
    Methods Mol Biol; 2012; 829():193-201. PubMed ID: 22231815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical and behavioral effects of m-CPP in a rat model of tardive dyskinesia.
    Ikram H; Samad N; Haleem DJ
    Pak J Pharm Sci; 2007 Jul; 20(3):188-95. PubMed ID: 17545102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
    Allan ER; Sison CE; Alpert M; Connolly B; Crichton J
    Psychopharmacol Bull; 1998; 34(1):71-4. PubMed ID: 9564201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
    Andrew HG
    Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anandamide attenuates haloperidol-induced vacuous chewing movements in rats.
    Röpke J; Busanello A; Leal CQ; de Moraes Reis E; de Freitas CM; Villarinho JG; Figueira FH; Mello CF; Ferreira J; Fachinetto R
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():195-9. PubMed ID: 24747871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms.
    Murphy JE; Stewart RB
    Am J Hosp Pharm; 1979 May; 36(5):641-4. PubMed ID: 36755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.